科兴控股生物技术有限公司宣布,其自主研发的水痘减毒活疫苗已获得尼泊尔药品监督管理局颁发的药品注册批件。这是该疫苗首次在海外获得注册批准,标志着科兴水痘疫苗进入国际市场。
Source Link科兴控股生物技术有限公司宣布,其自主研发的水痘减毒活疫苗已获得尼泊尔药品监督管理局颁发的药品注册批件。这是该疫苗首次在海外获得注册批准,标志着科兴水痘疫苗进入国际市场。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.